(Q48545304)

English

Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

0 references

erectile dysfunction

1 reference

based on heuristic

inferred from title

Peyronie's disease

1 reference

based on heuristic

inferred from title

Ferdinando Fusco

5

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

author name string

A Palmieri

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

C Imbimbo

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

M Creta

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

P Verze

4

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

V Mirone

6

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

publication date

15 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

International Journal of Andrology

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

35

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

190-195

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

Peyronie's disease: advances in basic science and pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

An alternative non-invasive treatment for Peyronie's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Experimental models of Peyronie's disease. Implications for new therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

A critical analysis of nonsurgical treatment of Peyronie's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: functional and satisfaction outcomes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Chronic PDE-5 inhibition in patients with erectile dysfunction: new treatment approach using once daily Tadalafil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Extracorporeal shock wave therapy in orthopedics. Assessment of an emerging health technology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2011.01226.X

21 January 2018

Identifiers

10.1111/J.1365-2605.2011.01226.X

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/22085227

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48545304&oldid=2201610784"